Latest Biotech News

A Nature Communications study identified a subpopulation of tight-junction–high, CDH17‑positive colorectal tumor cells as principal drivers of liver metastasis, reporting functional and molecular...

A Pediatric Research paper from Wolff and Koutroulis mapped serum immune biomarkers that correlate with disease severity and recovery trajectories in Multisystem Inflammatory Syndrome in Children...

A recent comparative study published in Biol Sex Differ reported that romosozumab outperformed parathyroid hormone (PTH 1–34) analogs in reducing osteoporotic fractures among women, finding...

A sector review on AI in digital pathology outlined recent innovations, validation challenges, and integration barriers that laboratories face when deploying machine‑learning tools for...

St. Jude Children’s Research Hospital published a new assay that improves detection of small off-target edits produced by base editors. The team released the method to enable researchers and...

The Phase II BEAVER trial reported clinical activity for the MEK inhibitor binimetinib combined with the BRAF inhibitor encorafenib in advanced solid tumors harboring non‑V600E BRAF alterations....

BioCentury’s finance roundup reports a significant market gain for Insilico following its Hong Kong listing. The coverage details the capital infusion and market valuation shifts that followed the...

BioCentury reports that Harmeier has returned to lead the Roche venture fund, a management move that revises leadership at one of Big Pharma’s principal corporate venture arms. The write‑up lists...

Hepta and collaborators announced a liquid biopsy technology and a landmark partnership to map the biology of metabolic dysfunction‑associated steatohepatitis (MASH). Hamed Amini described a...

A study led by Cabezas‑Caballero and colleagues reports engineered co‑signaling receptors that improve T cell precision by limiting off‑target activation. The team demonstrated that redesigned...

Researchers reported a Phase 1/2 trial testing autologous CD133+ bone marrow‑derived stem cells for Asherman syndrome, a fibrotic uterine condition. The trial evaluated feasibility, safety and...

A team introduced a live tumor‑fragment platform that preserves tumor architecture to assess immunotherapy responses ex vivo. The system allows drug exposure and readout of immune‑mediated tumor...

Researchers Wei, Liu and Zhou developed a fluorescent D‑amino acid labeling method to track Lactobacillus strains in vivo, enabling direct imaging of probiotic colonization and persistence. The...

A Pediatric Research study by Wolff and Koutroulis identified serum immune biomarkers that track severity and recovery in Multisystem Inflammatory Syndrome in Children (MIS‑C). The paper...

AbbVie struck a $1.1 billion deal to acquire ex‑China rights to Zelgen Biopharmaceuticals’ lead oncology asset, alveltamig (ZG‑006), a trispecific T‑cell engager targeting DLL3. The agreement...

Insilico Medicine saw a sharp market move following its Hong Kong listing, according to a BioCentury finance report. The biotech’s public debut delivered a material valuation uplift that traders...

Roche announced the return of Harmeier to head its venture fund, signaling a leadership reset at its corporate venture arm. BioCentury reported the management move on Jan. 2, 2026, as part of a...

Outlook Therapeutics received a third complete response letter (CRL) from the U.S. FDA for ONS‑5010, its bevacizumab biosimilar formulation for wet age‑related macular degeneration, prompting a...

The U.S. Drug Enforcement Administration extended temporary telemedicine prescribing flexibilities for controlled substances through the end of 2026, according to MedCity News. The fourth...

Psithera Inc. completed a spin‑out from Roivant and closed a $47.5 million Series A financing while appointing Eric Shaff as president and CEO, the company disclosed in late 2025. The new entity...